• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与超重。

Intestinal microbiota and overweight.

机构信息

Danisco Sweeteners, Health and Nutrition, Sokeritehtaantie 20, 02460 Kantvik, Finland.

出版信息

Benef Microbes. 2010 Nov;1(4):407-21. doi: 10.3920/BM2010.0030.

DOI:10.3920/BM2010.0030
PMID:21831779
Abstract

The microbes in our gut can influence our weight by providing us with energy through the degradation of nondigestable carbohydrates and by affecting the cellular energy status of liver and muscle cells and the accumulation of lipids in adipose tissue. Thus, it is not surprising that in several studies the gastrointestinal microbiota of overweight and obese subjects has been found to differ from that of lean subjects. The initial findings linked obesity with proportionally decreased levels of the phylum Bacteroidetes and increased levels of the phylum Firmicutes. Later, several studies have assessed the association between overweight or obesity and the gastrointestinal microbiota, applying an array of molecular methods targeting the microbiota as a whole or specific bacterial groups or species within. However, at present it is difficult to draw conclusions on which of the observed microbiota alterations are relevant; essentially all of the bacterial groups that have been studied in more than one trial have given contradictory results in regard to their association with weight. Some of these discrepancies can result from methodological issues and some from the nature of the gastrointestinal microbiota, which is an extremely complex and dynamic microbial ecosystem with high subject specificity. In addition, selecting subjects purely based on weight may result in a largely heterogeneous group with several potentially confounding factors. While it may be premature to conclude which specific groups of bacteria are prominent in the intestinal tract of overweight and obese subjects, it appears clear that microbes contribute to weight gain and related health issues, such as the metabolic syndrome and type II diabetes. Therefore, it is important to continue to search for common microbial markers and predictors of obesity, and to study how these may be modulated with probiotics and prebiotics to promote health.

摘要

肠道中的微生物可以通过降解不可消化的碳水化合物为我们提供能量,并影响肝脏和肌肉细胞的细胞能量状态以及脂肪组织中脂质的积累,从而影响我们的体重。因此,在多项研究中发现,超重和肥胖人群的胃肠道微生物群与体重正常人群的微生物群不同,这并不奇怪。最初的研究结果将肥胖与拟杆菌门的比例降低和厚壁菌门的比例升高联系起来。后来,有几项研究评估了超重或肥胖与胃肠道微生物群之间的关系,应用了一系列针对整个微生物群或特定细菌群或物种的分子方法。然而,目前很难得出结论哪些观察到的微生物群变化是相关的;基本上所有在一项以上试验中研究过的细菌群在与体重的关联方面都给出了相互矛盾的结果。这些差异中的一些可能是由于方法学问题,还有一些是由于胃肠道微生物群的性质,它是一个极其复杂和动态的微生物生态系统,具有很高的个体特异性。此外,纯粹根据体重选择研究对象可能会导致一个具有多种潜在混杂因素的高度异质群体。虽然现在就得出哪些特定的细菌群在超重和肥胖人群的肠道中占优势还为时过早,但很明显,微生物有助于体重增加和相关的健康问题,如代谢综合征和 2 型糖尿病。因此,继续寻找肥胖的常见微生物标志物和预测因子,并研究如何通过益生菌和益生元来调节这些标志物和预测因子以促进健康是很重要的。

相似文献

1
Intestinal microbiota and overweight.肠道微生物群与超重。
Benef Microbes. 2010 Nov;1(4):407-21. doi: 10.3920/BM2010.0030.
2
Microbiota and SCFA in lean and overweight healthy subjects.瘦素和超重健康受试者中的微生物群和 SCFA。
Obesity (Silver Spring). 2010 Jan;18(1):190-5. doi: 10.1038/oby.2009.167. Epub 2009 Jun 4.
3
The relationship between gut microbiota and weight gain in humans.人体肠道微生物群与体重增加之间的关系。
Future Microbiol. 2012 Jan;7(1):91-109. doi: 10.2217/fmb.11.142.
4
Intestinal microbiota in inflammation and insulin resistance: relevance to humans.肠道微生物群在炎症和胰岛素抵抗中的作用:与人类的相关性。
Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):334-40. doi: 10.1097/MCO.0b013e328347924a.
5
The intestinal microbiota and obesity.肠道微生物群与肥胖。
J Clin Gastroenterol. 2012 Jan;46(1):16-24. doi: 10.1097/MCG.0b013e31823711fd.
6
Prebiotic effects: metabolic and health benefits.益生元作用:代谢与健康益处。
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
7
[The association of intestinal microbiota with obesity].
Rev Med Chil. 2010 Aug;138(8):1020-7. Epub 2010 Nov 26.
8
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.靶向干预饮食诱导肥胖症中的肠道微生物群导致的代谢结果出现差异。
Gut. 2013 Feb;62(2):220-6. doi: 10.1136/gutjnl-2011-300705. Epub 2012 Feb 16.
9
Analysis of the intestinal microbiota of oligosaccharide fed mice exhibiting reduced resistance to Salmonella infection.分析摄入低聚糖的小鼠肠道微生物菌群,这些小鼠对沙门氏菌感染的抵抗力降低。
Benef Microbes. 2010 Sep;1(3):271-81. doi: 10.3920/BM2010.0016.
10
Intestinal microbiota and obesity.肠道微生物群与肥胖
Handb Exp Pharmacol. 2012(209):251-73. doi: 10.1007/978-3-642-24716-3_11.

引用本文的文献

1
Obesity, Gut Microbiota, and Metabolome: From Pathophysiology to Nutritional Interventions.肥胖、肠道微生物群和代谢组学:从病理生理学到营养干预。
Nutrients. 2023 May 9;15(10):2236. doi: 10.3390/nu15102236.
2
Role of vitamin D on gut microbiota in cystic fibrosis.维生素D在囊性纤维化患者肠道微生物群中的作用。
J Steroid Biochem Mol Biol. 2018 Jan;175:82-87. doi: 10.1016/j.jsbmb.2016.11.001. Epub 2016 Nov 3.
3
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.以微生物发酵代谢产物作为益生元健康益处的标志物。
Nutr Res Rev. 2015 Jun;28(1):42-66. doi: 10.1017/S0954422415000037.
4
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.肠道微生物群-脑轴及其对疑似免疫失调的神经精神疾病的影响。
Clin Ther. 2015 May 1;37(5):984-95. doi: 10.1016/j.clinthera.2015.04.002.
5
Synbiotics in Children with Cow's Milk Allergy: A Randomized Controlled Trial.益生菌合剂用于牛奶蛋白过敏儿童:一项随机对照试验。
Iran J Pediatr. 2014 Feb;24(1):29-34. Epub 2014 Jan 3.
6
The Metabolism of Polysaccharide from Atractylodes macrocephala Koidz and Its Effect on Intestinal Microflora.白术多糖的代谢及其对肠道微生物群的影响。
Evid Based Complement Alternat Med. 2014;2014:926381. doi: 10.1155/2014/926381. Epub 2014 Nov 19.
7
Infant antibiotic exposure and the development of childhood overweight and central adiposity.婴儿期抗生素暴露与儿童期超重及中心性肥胖的发展
Int J Obes (Lond). 2014 Oct;38(10):1290-8. doi: 10.1038/ijo.2014.119. Epub 2014 Jul 11.
8
Gut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease.肠道微生物群与临床疾病:肥胖症和非酒精性脂肪性肝病
Pediatr Gastroenterol Hepatol Nutr. 2013 Mar;16(1):22-7. doi: 10.5223/pghn.2013.16.1.22. Epub 2013 Mar 31.